{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:31:45Z","timestamp":1793381505662,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.remnie.2025.500255","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:16:49Z","timestamp":1764173809000},"page":"500255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the functional status of somatostatin receptors by 99mTc-octreotide scan in patients suffering from primary brain tumors"],"prefix":"10.1016","volume":"45","author":[{"given":"A.","family":"Aghaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Anvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kabiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mehravanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Barashki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2025.500255_bib0005","unstructured":"Wong ET, Wu JK. Overview of the clinical features and diagnosis of brain tumors in adults. Available at: https:\/\/www.uptodate.com\/contents\/5180 Accessed: 10 June 2024. 2024."},{"key":"10.1016\/j.remnie.2025.500255_bib0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1602\/neurorx.2.2.333","article-title":"Imaging in neurooncology","volume":"2","author":"Jacobs","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.remnie.2025.500255_bib0015","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.3390\/ijms23116079","article-title":"Neuroimaging modalities in Alzheimer\u2019s disease: diagnosis and clinical features","volume":"23","author":"Kim","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.remnie.2025.500255_bib0020","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.remnie.2025.500255_bib0025","first-page":"211","article-title":"Primary brain tumors in adults: diagnosis and treatment","volume":"93","author":"Perkins","year":"2016","journal-title":"Am Fam Physician"},{"issue":"7","key":"10.1016\/j.remnie.2025.500255_bib0030","first-page":"1053","article-title":"PET imaging of somatostatin receptors using [68GA] DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas","volume":"42","author":"Henze","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2025.500255_bib0035","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/neuonc\/nox101","article-title":"Diagnostic challenges in meningioma","volume":"19","author":"Nowosielski","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.remnie.2025.500255_bib0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00401-015-1459-3","article-title":"Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen","volume":"130","author":"Menke","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.remnie.2025.500255_bib0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3889\/oamjms.2018.062","article-title":"Value of SSTR2A and Claudin - 1 in differentiating meningioma from schwannoma and hemangiopericytoma","volume":"6","author":"Anis","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.remnie.2025.500255_bib0050","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3389\/fonc.2020.01633","article-title":"Clinical significance of somatostatin receptor (SSTR) 2 in meningioma","volume":"10","author":"Wu","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.remnie.2025.500255_bib0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11060-013-1146-y","article-title":"Correlation between 99m Tc-HYNIC-octreotide SPECT\/CT somatostatin receptor scintigraphy and pathological grading of meningioma","volume":"113","author":"Wang","year":"2013","journal-title":"J Neurooncol"},{"issue":"Apr (2)","key":"10.1016\/j.remnie.2025.500255_bib0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/snuc.2002.31022","article-title":"Somatostatin receptor imaging","volume":"32","author":"Kwekkeboom","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.remnie.2025.500255_bib0065","first-page":"1538","article-title":"Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE\/-TOC uptake","volume":"18","author":"Seystahl","year":"2016","journal-title":"Neuro Oncol"},{"issue":"Aug (9)","key":"10.1016\/j.remnie.2025.500255_bib0070","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/ph14090872","article-title":"Peptide receptor radionuclide therapy and primary brain tumors: an overview","volume":"14","author":"Cimini","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"Mar (2)","key":"10.1016\/j.remnie.2025.500255_bib0075","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/NI.Neurol-India-D-23-00252","article-title":"PRRT with Lu-177 DOTATATE in treatment-refractory progressive meningioma: initial experience from a tertiary-care neuro-oncology center","volume":"72","author":"Puranik","year":"2024","journal-title":"Neurol India"},{"key":"10.1016\/j.remnie.2025.500255_bib0080","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/cancers15030980","article-title":"Hormone receptor expression in meningiomas: a systematic review","volume":"15","author":"Agopiantz","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.remnie.2025.500255_bib0085","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/ijms25010436","article-title":"Somatostatin and somatostatin receptors in tumour biology","volume":"25","author":"Kumar","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.remnie.2025.500255_bib0090","first-page":"13185","article-title":"Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance","volume":"8","author":"de Oliveira Silva","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.remnie.2025.500255_bib0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13550-015-0106-2","article-title":"Somatostatin receptor subtype 2 in high-grade gliomas: PET\/CT with 68 Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy","volume":"5","author":"Kiviniemi","year":"2015","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.remnie.2025.500255_bib0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0972-3919.198487","article-title":"Somatostatin receptor SPECT\/CT using 99mTc labeled HYNIC-TOC aids in diagnosis of primary optic nerve sheath meningioma","volume":"32","author":"Chandra","year":"2017","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.remnie.2025.500255_bib0105","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3390\/diagnostics12071666","article-title":"Somatostatin receptor targeted PET-imaging for diagnosis, radiotherapy planning and theranostics of meningiomas: a systematic review of the literature","volume":"12","author":"Filippi","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.remnie.2025.500255_bib0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.14791\/btrt.2023.0022","article-title":"Value of Thallium-201 SPECT and SPECT\/CT brain imaging in differentiating malignant from nonmalignant lesions: a comparative case-series study with pathologic and\/or clinical correlation","volume":"11","author":"Pang","year":"2023","journal-title":"Brain Tumor Res Treat"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925001624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925001624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:54:18Z","timestamp":1793379258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808925001624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2253808925001624"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500255","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the functional status of somatostatin receptors by 99mTc-octreotide scan in patients suffering from primary brain tumors","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2025.500255","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500255"}}